Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Net income	$ 27,642	$ 26,281
Adjustments to reconcile net income to net cash from operating activities
Provision for credit losses	3,989	3,372
Depreciation, amortization and accretion	7,948	9,505
Compensation expense related to stock options and restricted stock awards	1,248	1,608
Change in cash surrender value of BOLI	(734)	(681)
Gain on sale of loans held for sale	(6,824)	(5,298)
Gain on sale of MSRs	(8,356)	0
Loss on sale of investment securities, net	7,836	0
Origination of loans held for sale	(426,672)	(292,309)
Proceeds from sale of loans held for sale	430,421	324,083
Gain on purchase of tax credits	(2,262)	0
Purchase of tax credits	(26,007)	0
Impairment of MSRs	545	0
Changes in operating assets and liabilities
Accrued interest receivable	(9)	(2,251)
Other assets	3,758	(4,074)
Other liabilities	(2,781)	4,798
Net cash from operating activities	9,742	65,034
CASH FLOWS (USED BY) FROM INVESTING ACTIVITIES
Proceeds from sale of investment securities	101,907	0
Maturities, prepayments, and calls	13,403	13,492
Purchases	(47,729)	(46,906)
Maturities of certificates of deposit at other financial institutions	14,874	0
Purchase of certificates of deposit at other financial institutions	(2,708)	(12,924)
Portfolio loan originations and principal collections, net	(37,873)	(150,385)
Net cash from acquisitions	0	336,157
Proceeds from sale of MSRs	16,311	0
Purchase of portfolio loans	(50,099)	(2,475)
Purchase of premises and equipment	(1,253)	(1,395)
Change in FHLB stock, net	(7,390)	6,915
Net cash (used by) from investing activities	(557)	142,479
CASH FLOWS USED BY FINANCING ACTIVITIES
Net decrease in deposits	(95,097)	(98,500)
Proceeds from borrowings	707,768	1,725,337
Repayments of borrowings	(637,708)	(1,789,970)
Dividends paid on common stock	(6,153)	(5,814)
(Disbursements) proceeds from stock options exercised, net	(1,284)	244
Common stock repurchased for employee/director taxes paid on restricted stock awards	(386)	(355)
Issuance of common stock - employee stock purchase plan	832	781
Common stock repurchased	(2,508)	0
Net cash used by financing activities	(34,536)	(168,277)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(25,351)	39,236
CASH AND CASH EQUIVALENTS, beginning of period	65,691	41,437
CASH AND CASH EQUIVALENTS, end of period	40,340	80,673
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION
Interest on deposits and borrowings	47,071	26,280
Income taxes	2,435	8,355
SUPPLEMENTARY DISCLOSURES OF NONCASH OPERATING, INVESTING AND FINANCING ACTIVITIES
Change in fair value on available-for-sale investment securities	11,689	(9,341)
Change in fair value on fair value and cash flow hedges	(5,288)	4,523
Change in fair value on portfolio loans measured under the fair value option	448	(285)
Retention in gross MSRs from loan sales	1,891	2,279
ROU assets in exchange for lease liabilities	0	2,034
Acquisitions:
Assets acquired	0	87,512
Liabilities assumed	$ 0	$ 424,949